H.R. 3 threatens access to medicines, future innovation and American jobs

In the last election, voters made clear that they want quality, affordable health coverage that works when they need it and lower out-of-pocket costs for medicines. And we can achieve those goals, but the drug pricing plan known as H.R. 3 is not the answer. If implemented, it could have devastating consequences for patients ’ access to medicines, future innovation and American jobs. Put simply, H.R. 3 is the wrong approach for both patients and the U.S. health care system. Here are some reasons why:
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Policy Solutions International Reference Pricing Proactive Agenda Source Type: news